Latest News about BIIB
Recent news which mentions BIIB
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
From Benzinga
From Motley Fool
From Benzinga
Biogen Sells Biosimilar-Venture Stake To Samsung Biologics For $2.3B
January 28, 2022
Tickers
BIIB
From Benzinga
3 Stocks That Have Been Paying Dividends for a Combined 447 Years
January 28, 2022
From Motley Fool
10 Biggest Price Target Changes For Monday
January 24, 2022
From Benzinga
Is Biogen a Buy?
January 22, 2022
From Motley Fool
3 Clinical Trials to Watch in the First Half of 2022
January 22, 2022
From Motley Fool
10 Biggest Price Target Changes For Tuesday
January 18, 2022
From Benzinga
Where Will Biogen Be in 5 Years?
January 15, 2022
From Motley Fool
4 Biotech Acquisitions We'd Like to See in 2022
January 14, 2022
From Motley Fool
3 Biotech Stocks to Buy That Are Under Severe Pressure
January 13, 2022
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2022
January 13, 2022
From Benzinga
Why Jim Cramer Prefers This Mining Stock Over Vale
January 13, 2022
From Benzinga
These S&P 500 stocks have cratered, but analysts think 12 can turn it around with rebounds of up to 70%
January 13, 2022
From MarketWatch
10 Biggest Price Target Changes For Thursday
January 13, 2022
From Benzinga
50 Biggest Movers From Yesterday
January 13, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 12, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 12, 2022
From Benzinga
28 Stocks Moving In Wednesday's Mid-Day Session
January 12, 2022
From Benzinga
Medicare pulls back on coverage of an Alzheimer’s drug
January 12, 2022
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For January 12, 2022
January 12, 2022
From Benzinga
Biogen’s stock tumbles after the U.S. proposes restricting access to its Alzheimer’s disease drug
January 12, 2022
From MarketWatch
Will This Stock's Pain Be Medicare's Gain?
January 12, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.